Weight gain after 12 months of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed HIV patients. Perez Barragan E, Guevara Maldonado MF, Mancilla Galindo J, Kammar Garcia A, et al. AIDS Res Hum Retroviruses 2023 Apr 18. doi: 10.1089/AID.2022.0130.

Read + Share

Amedeo Smart

Independent Medical Education

Perez Barragan E, Guevara Maldonado MF, Mancilla Galindo J, Kammar Garcia A, et al. Weight gain after 12 months of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed HIV patients. AIDS Res Hum Retroviruses 2023 Apr 18. doi: 10.1089/AID.2022.0130.
PMID: 37071218